Compare Twist Bioscience Corp (TWST) vs Vanguard Real Estate Index Fund ETF (VNQ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Twist Bioscience Corp vs Vanguard Real Estate Index Fund ETF — how do they compare? Twist Bioscience Corp trades at $159.78 (market cap $10.08B), while Vanguard Real Estate Index Fund ETF trades at $90.65 (market cap $70.80B). The key difference: Vanguard Real Estate Index Fund ETF is far larger — about 7× Twist Bioscience Corp's market cap, and Twist Bioscience Corp is trading nearer its 52-week high, Vanguard Real Estate Index Fund ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Twist Bioscience Corp for 27 Days and Vanguard Real Estate Index Fund ETF for 113 Days on average.
| TWST | VNQ | |
|---|---|---|
Market Cap | $10.08B | $70.80B |
Volume | 4,229,037 | 6,073,580 |
Sector | Health | — |
52-Week High | $205.00 | $100.95 |
52-Week Low | $25.45 | $87.00 |
Typical Hold Time | 27 Days | 113 Days |
Enterprise Value | $10.01B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Twist Bioscience (TWST) trades at $152.05, down 2.31% today but remains near recent highs following a significant rally driven by AI partnerships and strong sector interest. The company shows improving revenue growth ($377M in 2025) but continues to post substantial losses (-$78M net income). Technical indicators show mixed signals with bullish overall sentiment but bearish moving averages, while analyst consensus remains positive with 73% buy ratings.
TWST presents a high-risk, high-reward opportunity with strong growth potential through AI-driven drug discovery partnerships but faces significant execution risks amid persistent profitability challenges. The stock's valuation appears stretched given current fundamentals, requiring successful commercialization of pipeline assets to justify premium multiples.
VNQ trades at $89.35, up 0.74% today, but faces bearish technical signals with moving averages indicating selling pressure. The ETF has declined nearly 10% recently amid rising Treasury yields and Fed rate hikes, eroding its income appeal versus safer alternatives. Recent institutional buying by State Street Corp and Envestnet suggests some see value at current levels, while news highlights sector headwinds from interest rate sensitivity and oversupply concerns in certain real estate segments.
Outlook remains challenged by rising rates compressing REIT valuations, though contrarian investors see opportunity in discounted sector exposure. Key risks include prolonged high interest rates, economic slowdown impacting property demand, and competition from Treasury yields. The dividend yield advantage has narrowed significantly, requiring careful assessment of total return potential versus rate-sensitive alternatives.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Twist Bioscience Corp
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →About Vanguard Real Estate Index Fund ETF
The fund employs an indexing investment approach designed to track the performance of the MSCI US Investable Market Real Estate 25/50 Index, an index made up of stocks of large, mid-size, and small US companies within the real estate sector. The Advisor attempts to replicate the target index by seeking to invest all of its assets in the stocks that make up the index, in order to hold each stock in approximately the same proportion as its weighting in the index. It is non-diversified.
Read more on VNQ →
